Bionano announces peer-reviewed publication on the utility of combining ogm and wes for evaluation of pediatric leukemia

San diego, sept. 06, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced a peer-reviewed publication from researchers at the german cancer consortium (dktk) showing the utility of optical genome mapping (ogm) and whole-exome sequencing (wes) in better understanding the mutational landscape of pediatric b-cell precursor acute lymphoblastic leukemia (bcp-all). researchers compared the analysis of 60 pediatric bcp-all samples using traditional cytogenetic methods against ogm and wes, finding that ogm and wes may provide novel insights into disease development and progression.
BNGO Ratings Summary
BNGO Quant Ranking